Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19
순환하는 미토콘드리아 DNA는 COVID-19로 인한 중증 질병 및 사망률의 초기 지표입니다
Clinical Medicine
[키워드] Admission
age
assessment
Care
circulating
circulating cell
clinical
clinically
collected
Comorbidities
complement
COVID-19
COVID-19 therapy
damaged
died
DNA
elevated
funding
hospital
ICU
ICU admission
immunology
independent
independent of
independent risk factor
Inflammation
Inflammatory
Inflammatory marker
intensive care unit
intrinsically
intubation
marker
measure
Mitochondria
mitochondrial
mitochondrial DNA
Mortality
multivariate
multivariate regression analysis
NIH
nucleic acid
nucleic acids
outcome
outcomes
Patient
plasma sample
plasma samples
predict
Primary outcome
Program
quantitation
receiver operating characteristic
released
renal replacement therapy
replacement therapy
reported
required
Result
risk
Risk factors
Science
Secondary outcomes
Sex
solid organs
subject
target
therapy
Undetermined
university
Vasopressor
Washington
were used
with COVID-19
[DOI] 10.1172/jci.insight.143299 PMC 바로가기 [Article Type] Clinical Medicine
[DOI] 10.1172/jci.insight.143299 PMC 바로가기 [Article Type] Clinical Medicine